Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. - Wikidata - awgldk - TriplyDB

Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

http://www.wikidata.org/entity/Q35152804

about

Overexpression of IL-17RC associated with ocular sarcoidosis.Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans.Granuloma genes in sarcoidosis: what is new?Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis.Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.HLA associations and Löfgren's syndrome.Idiopathic giant cell myocarditis and cardiac sarcoidosis.Tuberculosis in the course of sarcoidosis treatment: is genotyping necessary for personalized therapy?Sarcoidosis: the links between epidemiology and aetiology.Interleukin-12 family cytokines and sarcoidosis.Etiologies of Sarcoidosis.Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.Cardiac sarcoidosis: diagnosis and management.Animal models of sarcoidosis.Characteristics of sarcoidosis in Maori and Pacific Islanders.Pulmonary sarcoidosis: an update.A Focus on the Epidemiology of Uveitis.SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility-A Joint Analysis in Four European Populations Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia.Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy.Local and Systemic CD4+ T Cell Exhaustion Reverses with Clinical Resolution of Pulmonary Sarcoidosis.Familial sarcoidosis: Report of a mother and her son.The "mystery" of cutaneous sarcoidosis: facts and controversies.Associations between sarcoidosis clinical course and ANXA11 rs1049550 C/T, BTNL2 rs2076530 G/A, and HLA class I and II alleles.HLA-alleles associated with increased risk for extra-pulmonary involvement in sarcoidosis Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis Next-Generation Sequencing Based HLA Typing: Deciphering Immunogenetic Aspects of Sarcoidosis

P2860

Q33762598-D31F3C8B-DEE8-4403-B51D-07B039CC967C Q35372594-99BC96BC-7D74-4DCE-8136-0A2B1F447862 Q36049206-3FDFA83E-6EA1-413E-98BF-50EC163C654F Q36057780-B1EDFDFA-6B5B-4852-8293-042EFE349E99 Q37149410-E5D82BC5-7532-4FA5-9EB6-7D11D19933ED Q37470312-581BD197-8DEC-4A7A-A62B-864FC3925FEC Q37965602-D68A51A3-0B86-430B-B91F-24F73C897087 Q38056618-C34D9AD2-C96A-417D-B435-45BCC0A02DD9 Q38096028-3FD6C714-210B-44B3-A40D-8B596417CC04 Q38250587-BB57E0D4-C72E-4C15-8EC3-91D2597652D3 Q38266881-413E09A8-807A-4804-B796-14319D9C0285 Q38378282-1A39EEF1-A9A6-4A82-AA09-4891A0E15AB0 Q38384482-6149C8E2-0E8E-44D1-947D-E39AE53B0A91 Q38541252-816B64F2-7529-4624-A192-31653C5F96E1 Q38799804-1452A2C9-F030-40F0-9406-BBF115AC0050 Q38978689-6A2D8973-5920-4991-A2F9-F37EBAA457C8 Q38987225-7593625B-210A-46DC-A66B-9ACBFF81C3E1 Q39551002-5F9A9D90-D50A-44E7-BC2A-C61CB9E9D18B Q42291117-E2CA1A9B-5059-4C4D-B962-4415C141F001 Q44194731-F6CAF04D-9086-4FD2-AD93-3BB762AC6CFF Q44892602-2AD6E683-E97A-4139-B689-0BAAD1D0BC9B Q46503075-9F0B95AB-D6A4-48DE-B339-3F75BC3639BE Q46724858-DC7619B2-CB1B-4D18-94CE-91374BBE34B7 Q47098219-0FA5145A-7ECA-47B4-9D31-34127EC7C887 Q48770953-0727A893-3BF0-45D9-AD64-7AA2FB6D42E6 Q51796555-02993448-EF39-4E78-820C-BB8DC1572D62 Q57536972-2325FA18-62E3-49C4-A334-63223C6EA014 Q58296375-9C4F1947-0884-4D76-A070-2C470A8E40EC Q58556154-5249E1B4-3FE7-4513-80F7-246A6B00668E

P2860

Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

http://www.wikidata.org/entity/Q35152804

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Sarcoidosis HLA class II genot ...... henotype across ethnic groups.

@en

type

label

Sarcoidosis HLA class II genot ...... henotype across ethnic groups.

@en

prefLabel

Sarcoidosis HLA class II genot ...... henotype across ethnic groups.

@en

P1433

Q35152804-A019682F-83B5-4683-9BE0-595FB5338A22

P1476

Q35152804-542FDDF1-19BF-43F5-A9D0-D06456E5915A

P2093

Q35152804-10A93E79-0A33-4DD5-96ED-9DB48FABD703

Q35152804-2489D756-27AD-4F95-B86E-8CE32DB9A425

Q35152804-2D1EA923-A3FD-49B1-A0C0-59B40053641F

Q35152804-3041BB8F-C5B8-41B9-BA49-A48987E0C9A0

Q35152804-46D327C5-D6BE-45E5-B704-CFCE7492B88A

Q35152804-50AACDE3-B792-43D5-A9A3-9AD3FFB24432

Q35152804-5CD06A70-D993-4074-9B51-EC07D16F963E

Q35152804-7DDA9398-DB73-40FF-937F-2E8D0A53EBCF

Q35152804-A55AB752-5F40-4E6A-AC71-A51C3C30B3D4

Q35152804-EB287333-7E6E-4007-9750-2B20ACE46A5F

P2860

Q35152804-085CFA65-5546-4373-9B02-2579EBABA96C

Q35152804-11AAD149-B38B-4AF1-B127-9465A618C11B

Q35152804-2E09B065-AB88-47C5-B3BE-F5BCD8591DB4

Q35152804-3FBFAAE4-51BD-401A-9E33-663DAB1BD5C5

Q35152804-42FE5031-25EE-47CC-80A2-66BBE159B2BE

Q35152804-4C2676A4-E896-4352-B158-B4096035DFCB

Q35152804-50BFEF01-5618-41BC-8F07-69E95CA80E89

Q35152804-54A4A3DE-B8D4-4DAB-8D52-EC5C21D6CCD5

Q35152804-57962208-CB02-4A48-97C1-112471D1A435

Q35152804-5AB8DDBC-7A61-42BD-AF3B-A6E070B50B96

P304

Q35152804-3ADE286B-574E-411B-A0B6-C4738C77BD50

P31

Q35152804-330E9543-0F57-477D-B092-D04F0BE26CE1

P356

Q35152804-522782E9-B104-4F5D-8949-FC4C85C334D6

P433

Q35152804-62EA72B9-430B-454E-8490-9A992CF6EE41

P478

Q35152804-C2D65769-28FD-47BF-8E65-F627E2180609

P50

Q35152804-F41B2AA2-035E-41DE-8BE9-A6918C7041CA

P577

Q35152804-8D5FFEC1-722D-4C6A-A9F3-EC71B30FD29A

P5875

Q35152804-5CC1320F-918B-497C-9137-8D4DAB39C8A7

P698

Q35152804-50BD7DCB-8A1D-4874-9D88-80950FDCC757

P932

Q35152804-0AC9794C-94BB-40D7-83F5-E501CB06321A

P356

P1433

Human Molecular Genetics

P1476

Sarcoidosis HLA class II genot ...... phenotype across ethnic groups

@en

P2093

Athol U Wells

http://www.w3.org/2001/XMLSchema#string

Hiroe Sato

http://www.w3.org/2001/XMLSchema#string

Jan C Grutters

http://www.w3.org/2001/XMLSchema#string

Jules M M van den Bosch

http://www.w3.org/2001/XMLSchema#string

Kenneth I Welsh

http://www.w3.org/2001/XMLSchema#string

Lee S Newman

http://www.w3.org/2001/XMLSchema#string

Lisa A Maier

http://www.w3.org/2001/XMLSchema#string

Paolo Spagnolo

http://www.w3.org/2001/XMLSchema#string

Roland M du Bois

http://www.w3.org/2001/XMLSchema#string

Sonoko Nagai

http://www.w3.org/2001/XMLSchema#string

P2860

The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization

Influence of MHC CLASS II in susceptibility to beryllium sensitization and chronic beryllium disease

SKDM human leukocyte antigen (HLA) tool: a comprehensive HLA and disease associations analysis software

Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis

Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.

Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients

Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population

Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101.

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis.

P304

4100-4111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDQ325

http://www.w3.org/2001/XMLSchema#string

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Felix A Woodhead

P577

2010-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45505091

http://www.w3.org/2001/XMLSchema#string

P698

20685690

http://www.w3.org/2001/XMLSchema#string

P932

4351376

http://www.w3.org/2001/XMLSchema#string